Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
China Ups Role of Hospital Pharmacy Affairs as NRDL Negotiation Concludes
Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on government's latest shift to upgrade hospital pharmacy af... (8/1/2017)
   
Can Tax Breaks Boost Private Health Insurance in China? (8/15/2017)
New Research Compares Drug Regulators Around the Globe (8/15/2017)
Beijing Courts Issued Consequential Judgments On Life-Science Patents (8/15/2017)
China's Proposed Control of Biological Resources Alerts Korean Drugmakers (8/10/2017)
China Joins ICH in Pursuit of Global Harmonization of Drug Development Standards (8/10/2017)
Ten Years and $100M+ Later, GSK Shutters a China R&D Site amid Reorganization (8/8/2017)
BeyondSpring Pharma: Communicating Across US-China Lines (8/8/2017)
FDA Proposes Patent Linkage Mechanism and Terms for Data Exclusivity for Public Comments (8/8/2017)
China Ups Role of Hospital Pharmacy Affairs as NRDL Negotiation Concludes (8/1/2017)
Review of Chinese Pharma Deals, R&D and Regulatory Developments in H1/2017 (8/1/2017)
Cancer in the Asia-Pacific, a CRO Perspective (7/13/2017)
Fast-tracking the Introduction of New Drugs (7/13/2017)
Branded Generics in the Emerging Markets (7/12/2017)
FT: Fosun Shares Slide As Group Denies Loss of Contact With Chairman (7/7/2017)
Why Big Pharma Is Targeting China's Deadliest Diseases (7/5/2017)
CFDI to Initiate Clinical Data Inspectio...  (8/18/2017)
CFDA Approves BMS's Baraclude as First P...  (8/18/2017)
CFDA Issues Announcement to Clarify Over...  (8/18/2017)
Ascletis In-licenses Medivir's Novel HCV...  (8/18/2017)
50 Domestically-listed Chinese Pharma Co...  (8/18/2017)
WuXi Biologics and Gloria Pharma Outlice...  (8/17/2017)
Recent Executive Moves  (8/17/2017)
GSK, AliHealth Join Hands to Build Vacci...  (8/17/2017)
China Sets Up New IP Rights Center for M...  (8/17/2017) (free)
Prometic Seals Joint Venture and Licensi...  (8/16/2017)
Zai Lab Files for NASDAQ IPO  (8/16/2017)
Smoking-unrelated Lung Cancer Jumps in C...  (8/16/2017)
Antengene Raises $21M in Series A Financ...  (8/15/2017) (free)
HitGen, Aduro Form New Drug Discovery Pa...  (8/15/2017)
China Issues Interpretations for Applica...  (8/15/2017)
White House Task Force Echoes Pharma Proposals
Pharma Industry Reputation Rebounds Somewhat in 2016
Fresenius Steps Up Pharma M&A with Akorn, Merck KGaA...
Global Pharmerging Market to Grow at a CAGR of 12.88% in...
PhRMA Urges USTR to Protect US Innovation Abroad
Chinese Human Vaccine Market To Rise Quickly Before 2021
The APAC Colorectal Cancer Market Set to Grow by 7.9% CAGR Befo...
Review of Chinese Retail Pharmacy Sales 2013-2016
Chinese Cancer Intervention Market to Grow Double-Digits
Nicholas Hall Reports MAT Q1/2017 Data on the Chinese OTC / OTC...
CFDA Approves BMS's Baraclude as First Pediatric HBV Drug in...
Ascletis In-licenses Medivir's Novel HCV Drug Candidate
50 Domestically-listed Chinese Pharma Companies Report H1 Pe...
WuXi Biologics and Gloria Pharma Outlicense PD-1 Antibody to...
GSK, AliHealth Join Hands to Build Vaccine Promotion Channel...
CFDI to Initiate Clinical Data Inspection of 32 Drug Pro...
CFDA Issues Announcement to Clarify Over Published Refer...
NDRC Solicits Comments on Pricing Guideline for Shortage...
CFDA Issues National Drug Abuse Monitoring Annual Report...
China to Introduce Price Guidelines for APIs of Shortage...
China Sets Up New IP Rights Center for Manufacturing and Bio...
China Issues Interpretations for Application of Criminal Law...
USTR Promises Thorough Investigation of China's IP Practices...
China Moves Up to No. 22 in 2017 Global Innovation Index
NDRC Penalizes Two More Monopolistic API Producers
French Authority Warns Chongqing API Producer over GMP V...
Another Chinese API Producer in Data Integrity Mudpool a...
U.S. FDA Warns Chinese API Producer for Absence of Writt...
India to Make Key APIs to Reduce Dependence on China
DSM Sinochem Pharmaceuticals Boosts Manufacturing Capaci...
NIH Quietly Proposes to Grant Salubris Rights to A Portf...
Tyme Receives Notice of Allowance of Patent for SM-88 in...
DelMar Pharma Cleared to Initiate Phase 2 Clinical Trial...
SillaJen and Lee's Pharma Approved to Commence Phase III...
China Accepts Propanc Biopharma's Patent Application for...
Smoking-unrelated Lung Cancer Jumps in China
Lung Cancer Incidence Jumps in China with Smog Blamed
First Expert Committee of National Clinical Medicine Res...
NHFPC Holds 2017 National Drug Administrative Conference...
State Council Issues Guidance Opinion for Modern Hospita...
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Recent Official and Executive Moves
Recent Executive Moves
Upcoming Event: Annual Biopharma Innovation Conference 2...
Sino-Japanese Symposium on Pharmaceuticals and Medical D...
Upcoming Event: Biopharma Development & Producti...
Upcoming Event: 4th Annual PharmaCon Asia
Upcoming Event: ISPE Conference and Exhibition 2017
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links